Supurva Healthcare Group Inc (SPRV)

[Saving Grace]

The projected deadline isn't up yet for the LOI to make such a determination and claim as it's not even up yet. LoL

Here is a little breakdown that is streamlined.

In the first quarter of 2015, the Company completed its transition away from the oil and gas
business. On March 24, 2015, entered into an exchange agreement with the members of Supurva
Healthcare Group, LLC, a Texas limited liability company (“Supurva LLC”) whereby the
Company acquired all of the outstanding membership units of Supurva LLC in exchange for the
issuance of 67,500 shares of Series D Preferred Shares to those members.

Member Series D Preferred Shares
Arthur Hood 2,025
Hood Global Investment Holdings, LLC1
40,163
D. Lee Rodger 6,750
Gerard Danos 18,562
Totals 67,500

During the quarter ending June 30, 2015, Hood Global Investment Holdings, LLC transferred 18,689 Series D Preferred Shares
to Gerard Danos and 13,500 Series D Preferred Shares to two other individuals leaving Hood Global Investment Holdings, LLC
with 7,094 Series D Preferred Shares.

In the first quarter of 2015, the Company completed its transition away from the oil and gas
business. On March 24, 2015, entered into an exchange agreement with the members of Supurva
Healthcare Group, LLC, a Texas limited liability company (“Supurva LLC”) whereby the
Company acquired all of the outstanding membership units of Supurva LLC in exchange for the
issuance of 67,500 shares of Series D Preferred Shares to those members.

The Company is currently looking to expand its on-site solution business through acquisitions. In
July 2015, the Company entered into a non-binding letter of intent to acquire Telemend Medical,
an onsite dental provider with business interests located in the Greater Houston Metropolitan area.
Telemend currently has service contracts with 35 skilled nursing and assisted living facilities. In
addition, Telemend has clinical engineering contracts with various government entities
nationwide. The acquisition is subject to the reasonable due diligence by the parties and is
expected to close in the fourth quarter of 2015.
expected to close in the fourth quarter of 2015.
expected to close in the fourth quarter of 2015.
expected to close in the fourth quarter of 2015.
In the Fourth Quarter meaning up until Dec. 31 2015
http://www.otcmarkets.com/financialReportViewer?symbol=SPRV&id=143435

Since the announcement Telemend now has a reported 13 employees and Supurva added 8 additional positions in the Houston area building their foundation.

Sheeneka Rains has been seated and excepted the position of COO of Supurva on July 21, 2015 confirmed on Bloomberg and Zoominfo. She is also in many spokeo circles I can display later.

Ms. Sheneka Rains, BSEE, CBET has been Chief Operating Officer at Supurva Healthcare Group, Inc. since July 21, 2015. Ms. Rains served as Vice President of Clinical Engineering at Rosellini Scientific, LLC. Ms. Rains served as Director of Clinical Engineering at Rosellini Scientific, LLC. She joined the Rosellini Scientific in 2012 and has a wealth of knowledge and experience in Healthcare Technology Management. She began her career with MediSend International where she took on the challenging role of teaching Clinical Engineering principles to Biomedical Engineers native to the healthcare systems of the developing world. Ms. Rains holds a Bachelor of Science in Electronic Engineering and the nationally recognized CBET (Certified Biomedical Equipment Technician) certification.

http://www.bloomberg.com/research/stocks/private/person.asp?personId=225427429&privcapId=305976658

Background
Employment History
Director of Clinical Engineering
Rosellini Scientific LLC
Member, Leadership Team
Rosellini Scientific LLC
Chief Executive Officer
TeleMend Medical, Inc.
Chief Operating Officer
Supurva Healthcare Group LLC
Education
BSEE
Bachelor of Science , Electronic Engineering

http://www.zoominfo.com/p/Sheneka-Rains/-1809440578

The facts presented are facts that are indisputable and absolute FACT

It is what it is without a doubt.